Jun 06, 2017
In the last day of ASCO 2017 annual meeting on Tuesday, researchers presented the data of Dacomitinib that delayed the growth of the lung cancer longer than Gefitinib, trademarked as Iressa in newly diagnosed patients.
2. Feb 15, 2019
Can we repair the brain? The promise of stem cell technologies for treating parkinson's disease
3. Feb 15, 2019
Singapore Beaches hounded by microplastics with pathogenic bacteria
4. Feb 15, 2019
Graphene-based supercapacitor has the potential to power wearable electronics